HDAC2 and esophageal squamous cell carcinoma: The functional study revealed that inhibition of HDAC2 strongly weakened the effects of TRIB2 on the sphere‐formation capacity, CSC marker expression, and CD90+ and CD271+ subpopulations of ESCC cells (Figure 7A–D).